 Jon Reuter
Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rodent Diseases | 5 | 2019 | 27 | 1.220 |
Why?
| | Deer | 2 | 2018 | 30 | 1.160 |
Why?
| | Housing, Animal | 3 | 2014 | 47 | 0.880 |
Why?
| | Animals, Laboratory | 3 | 2014 | 17 | 0.860 |
Why?
| | Muromegalovirus | 4 | 2008 | 21 | 0.820 |
Why?
| | Behavior, Animal | 3 | 2025 | 490 | 0.780 |
Why?
| | Monkey Diseases | 4 | 2014 | 19 | 0.750 |
Why?
| | Animal Husbandry | 2 | 2011 | 38 | 0.730 |
Why?
| | Whistleblowing | 1 | 2020 | 3 | 0.700 |
Why?
| | Hemorrhagic Disease Virus, Epizootic | 1 | 2018 | 2 | 0.610 |
Why?
| | Bluetongue | 1 | 2018 | 5 | 0.610 |
Why?
| | Parvoviridae Infections | 3 | 2019 | 11 | 0.600 |
Why?
| | Dermacentor | 1 | 2017 | 1 | 0.580 |
Why?
| | Rhipicephalus | 1 | 2017 | 2 | 0.580 |
Why?
| | Tick Infestations | 1 | 2017 | 3 | 0.580 |
Why?
| | Zika Virus | 1 | 2018 | 77 | 0.560 |
Why?
| | Chikungunya Fever | 1 | 2018 | 74 | 0.560 |
Why?
| | Chikungunya virus | 1 | 2018 | 74 | 0.550 |
Why?
| | Genetic Vectors | 3 | 2017 | 311 | 0.540 |
Why?
| | Altitude | 1 | 2021 | 443 | 0.540 |
Why?
| | Animal Care Committees | 1 | 2016 | 5 | 0.530 |
Why?
| | Animal Welfare | 1 | 2016 | 13 | 0.520 |
Why?
| | Herpesviridae Infections | 3 | 2008 | 134 | 0.520 |
Why?
| | Viral Vaccines | 3 | 2008 | 93 | 0.510 |
Why?
| | Oxyuriasis | 1 | 2014 | 1 | 0.480 |
Why?
| | Oxyuroidea | 1 | 2014 | 1 | 0.480 |
Why?
| | Anxiety | 1 | 2021 | 949 | 0.450 |
Why?
| | Hypoxia | 1 | 2021 | 1031 | 0.440 |
Why?
| | Brain Abscess | 1 | 2013 | 10 | 0.430 |
Why?
| | Implants, Experimental | 1 | 2013 | 18 | 0.430 |
Why?
| | Cytomegalovirus Infections | 2 | 2005 | 187 | 0.420 |
Why?
| | Craniotomy | 1 | 2013 | 70 | 0.410 |
Why?
| | Macaca mulatta | 4 | 2014 | 146 | 0.410 |
Why?
| | Virus Shedding | 1 | 2012 | 41 | 0.400 |
Why?
| | Animals | 26 | 2025 | 34501 | 0.390 |
Why?
| | Depression | 1 | 2021 | 1289 | 0.390 |
Why?
| | Mice | 13 | 2025 | 16579 | 0.380 |
Why?
| | Minute Virus of Mice | 1 | 2011 | 1 | 0.370 |
Why?
| | Brain | 5 | 2013 | 2618 | 0.370 |
Why?
| | Endemic Diseases | 1 | 2011 | 30 | 0.360 |
Why?
| | Sanitation | 1 | 2011 | 52 | 0.360 |
Why?
| | Drinking Water | 1 | 2011 | 76 | 0.340 |
Why?
| | Inflammation | 1 | 2021 | 2664 | 0.340 |
Why?
| | Rabbits | 4 | 2005 | 761 | 0.320 |
Why?
| | Vesiculovirus | 1 | 2008 | 15 | 0.300 |
Why?
| | United States Virgin Islands | 2 | 2018 | 2 | 0.300 |
Why?
| | Viral Envelope Proteins | 1 | 2008 | 81 | 0.280 |
Why?
| | Rats, Long-Evans | 3 | 2025 | 118 | 0.280 |
Why?
| | Immunocompromised Host | 2 | 2005 | 195 | 0.270 |
Why?
| | Antibody Formation | 1 | 2008 | 287 | 0.270 |
Why?
| | Cottontail rabbit papillomavirus | 2 | 2004 | 2 | 0.260 |
Why?
| | Vesicular stomatitis Indiana virus | 2 | 2004 | 13 | 0.260 |
Why?
| | Viral Structural Proteins | 2 | 2004 | 12 | 0.260 |
Why?
| | Immunity, Cellular | 1 | 2008 | 267 | 0.260 |
Why?
| | Animal Feed | 2 | 2019 | 52 | 0.250 |
Why?
| | Antigens, Viral | 2 | 2004 | 174 | 0.240 |
Why?
| | Iatrogenic Disease | 1 | 2005 | 55 | 0.240 |
Why?
| | Pneumothorax | 1 | 2005 | 40 | 0.240 |
Why?
| | Parvovirus | 2 | 2019 | 13 | 0.230 |
Why?
| | Central Nervous System Diseases | 1 | 2005 | 66 | 0.230 |
Why?
| | Circadian Rhythm | 2 | 2025 | 405 | 0.220 |
Why?
| | Brain Diseases | 1 | 2005 | 134 | 0.220 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2004 | 62 | 0.220 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 45 | 0.200 |
Why?
| | Light | 1 | 2025 | 355 | 0.200 |
Why?
| | Papillomavirus Infections | 2 | 2004 | 291 | 0.200 |
Why?
| | Lymphocytes | 2 | 2021 | 366 | 0.190 |
Why?
| | Encephalitis | 1 | 2004 | 132 | 0.190 |
Why?
| | Fracture Healing | 1 | 2002 | 77 | 0.190 |
Why?
| | Femoral Fractures | 1 | 2002 | 74 | 0.190 |
Why?
| | Endophenotypes | 1 | 2021 | 18 | 0.180 |
Why?
| | Anhedonia | 1 | 2021 | 11 | 0.180 |
Why?
| | Granulocytes | 1 | 2021 | 79 | 0.180 |
Why?
| | Swimming | 1 | 2021 | 47 | 0.180 |
Why?
| | Dietary Sucrose | 1 | 2021 | 48 | 0.180 |
Why?
| | Respiration, Artificial | 1 | 2005 | 594 | 0.180 |
Why?
| | Mice, SCID | 4 | 2005 | 345 | 0.180 |
Why?
| | Feces | 2 | 2014 | 432 | 0.180 |
Why?
| | Postoperative Care | 1 | 2002 | 243 | 0.180 |
Why?
| | Pasteurella Infections | 1 | 2000 | 1 | 0.180 |
Why?
| | Femur | 1 | 2002 | 244 | 0.170 |
Why?
| | Mice, Mutant Strains | 1 | 2000 | 292 | 0.170 |
Why?
| | Caliciviridae Infections | 1 | 2019 | 17 | 0.160 |
Why?
| | Eye Diseases | 1 | 2000 | 78 | 0.160 |
Why?
| | Norovirus | 1 | 2019 | 23 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2005 | 1046 | 0.160 |
Why?
| | Rats | 3 | 2025 | 5168 | 0.160 |
Why?
| | Rhabdomyolysis | 1 | 1998 | 20 | 0.150 |
Why?
| | Bluetongue virus | 1 | 2018 | 4 | 0.150 |
Why?
| | DNA, Viral | 2 | 2012 | 348 | 0.150 |
Why?
| | Green Fluorescent Proteins | 3 | 2012 | 382 | 0.150 |
Why?
| | Animal Experimentation | 1 | 2017 | 6 | 0.140 |
Why?
| | Introduced Species | 1 | 2017 | 36 | 0.140 |
Why?
| | T-Lymphocytes | 2 | 2005 | 1922 | 0.140 |
Why?
| | Droughts | 1 | 2017 | 39 | 0.140 |
Why?
| | Zika Virus Infection | 1 | 2018 | 102 | 0.130 |
Why?
| | Education, Veterinary | 1 | 2016 | 3 | 0.130 |
Why?
| | Veterinary Medicine | 1 | 2016 | 7 | 0.130 |
Why?
| | Viruses | 1 | 2017 | 99 | 0.130 |
Why?
| | Apoptosis | 1 | 2005 | 2437 | 0.130 |
Why?
| | DNA, Recombinant | 2 | 2008 | 46 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2245 | 0.130 |
Why?
| | Neutralization Tests | 2 | 2008 | 72 | 0.120 |
Why?
| | Seizures | 1 | 2019 | 395 | 0.120 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2008 | 60 | 0.120 |
Why?
| | Administration, Intranasal | 2 | 2008 | 81 | 0.120 |
Why?
| | Enterobius | 1 | 2014 | 1 | 0.120 |
Why?
| | Bedding and Linens | 1 | 2014 | 10 | 0.120 |
Why?
| | Eyeglasses | 1 | 2014 | 5 | 0.120 |
Why?
| | Astigmatism | 1 | 2014 | 10 | 0.120 |
Why?
| | Vision, Ocular | 1 | 2014 | 33 | 0.110 |
Why?
| | Occupational Health | 1 | 2017 | 195 | 0.110 |
Why?
| | Myopia | 1 | 2014 | 47 | 0.110 |
Why?
| | Occupational Exposure | 1 | 2017 | 309 | 0.110 |
Why?
| | Female | 10 | 2025 | 68127 | 0.110 |
Why?
| | Mice, Inbred BALB C | 3 | 2005 | 1229 | 0.100 |
Why?
| | Mice, Inbred ICR | 1 | 2012 | 110 | 0.100 |
Why?
| | Male | 8 | 2025 | 62883 | 0.100 |
Why?
| | Dependovirus | 1 | 2012 | 60 | 0.100 |
Why?
| | Phenotype | 1 | 2000 | 3050 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1019 | 0.090 |
Why?
| | Food Irradiation | 1 | 2011 | 1 | 0.090 |
Why?
| | DNA Primers | 1 | 2012 | 510 | 0.090 |
Why?
| | Equipment Failure Analysis | 1 | 2011 | 131 | 0.090 |
Why?
| | Gamma Rays | 1 | 2011 | 52 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 402 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 582 | 0.090 |
Why?
| | Prevalence | 1 | 2017 | 2549 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 937 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2019 | 5257 | 0.080 |
Why?
| | Disinfection | 1 | 2011 | 117 | 0.080 |
Why?
| | Seasons | 1 | 2011 | 498 | 0.080 |
Why?
| | Motor Activity | 2 | 2025 | 667 | 0.070 |
Why?
| | Risk Assessment | 2 | 2017 | 3256 | 0.070 |
Why?
| | Murine hepatitis virus | 1 | 2007 | 16 | 0.070 |
Why?
| | Sentinel Surveillance | 1 | 2007 | 39 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2004 | 266 | 0.060 |
Why?
| | Spleen | 1 | 2008 | 513 | 0.060 |
Why?
| | Luminescent Proteins | 2 | 2004 | 176 | 0.060 |
Why?
| | Immunization | 1 | 2008 | 411 | 0.060 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2025 | 15 | 0.060 |
Why?
| | Antibodies, Viral | 3 | 2007 | 593 | 0.060 |
Why?
| | Myelin Basic Protein | 1 | 2005 | 46 | 0.060 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2005 | 20 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2005 | 120 | 0.060 |
Why?
| | Adoptive Transfer | 1 | 2005 | 216 | 0.060 |
Why?
| | Conditioning, Operant | 1 | 2025 | 103 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2008 | 761 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2005 | 93 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2005 | 301 | 0.060 |
Why?
| | Melatonin | 1 | 2025 | 121 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2005 | 163 | 0.060 |
Why?
| | Photic Stimulation | 1 | 2025 | 240 | 0.060 |
Why?
| | Cytomegalovirus | 1 | 2005 | 153 | 0.060 |
Why?
| | Caspase 3 | 1 | 2005 | 229 | 0.060 |
Why?
| | Caspases | 1 | 2005 | 242 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2005 | 3943 | 0.050 |
Why?
| | Viremia | 1 | 2004 | 130 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2004 | 129 | 0.050 |
Why?
| | Hindlimb Suspension | 1 | 2002 | 21 | 0.050 |
Why?
| | Anisocoria | 1 | 2001 | 2 | 0.050 |
Why?
| | Mice, Nude | 1 | 2004 | 682 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2008 | 840 | 0.050 |
Why?
| | Coronavirus Infections | 1 | 2007 | 335 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 538 | 0.040 |
Why?
| | Monocytes | 1 | 2004 | 541 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2001 | 92 | 0.040 |
Why?
| | Pasteurella | 1 | 2000 | 1 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1284 | 0.040 |
Why?
| | Fas Ligand Protein | 1 | 2000 | 59 | 0.040 |
Why?
| | Lung | 2 | 2005 | 3741 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2000 | 68 | 0.040 |
Why?
| | fas Receptor | 1 | 2000 | 95 | 0.040 |
Why?
| | Lymphoproliferative Disorders | 1 | 2000 | 53 | 0.040 |
Why?
| | Glomerulonephritis | 1 | 2000 | 47 | 0.040 |
Why?
| | Range of Motion, Articular | 1 | 2002 | 387 | 0.040 |
Why?
| | Fracture Fixation, Internal | 1 | 2002 | 222 | 0.040 |
Why?
| | Radiography | 1 | 2002 | 864 | 0.040 |
Why?
| | Ethosuximide | 1 | 2019 | 1 | 0.040 |
Why?
| | Rodentia | 1 | 2019 | 47 | 0.040 |
Why?
| | Eye | 1 | 2000 | 103 | 0.040 |
Why?
| | Food Handling | 1 | 2019 | 60 | 0.040 |
Why?
| | Electrocorticography | 1 | 2019 | 13 | 0.040 |
Why?
| | Animals, Wild | 1 | 2019 | 50 | 0.040 |
Why?
| | Atropine | 1 | 1998 | 24 | 0.040 |
Why?
| | Anorexia | 1 | 1998 | 19 | 0.040 |
Why?
| | Knee Joint | 1 | 2002 | 366 | 0.040 |
Why?
| | Cefazolin | 1 | 1998 | 16 | 0.040 |
Why?
| | Creatine Kinase | 1 | 1998 | 75 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 1998 | 85 | 0.040 |
Why?
| | Myositis | 1 | 1998 | 52 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 1998 | 150 | 0.040 |
Why?
| | Ketamine | 1 | 1998 | 84 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 466 | 0.040 |
Why?
| | Social Control, Formal | 1 | 2017 | 11 | 0.040 |
Why?
| | Vaccination | 2 | 2004 | 1336 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2019 | 197 | 0.030 |
Why?
| | Movement | 1 | 2019 | 267 | 0.030 |
Why?
| | Electroencephalography | 1 | 2019 | 393 | 0.030 |
Why?
| | Skin | 1 | 2000 | 717 | 0.030 |
Why?
| | Biopsy | 1 | 1998 | 1085 | 0.030 |
Why?
| | Vision Tests | 1 | 2014 | 16 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1998 | 1416 | 0.030 |
Why?
| | Refraction, Ocular | 1 | 2014 | 36 | 0.030 |
Why?
| | Kidney | 1 | 2000 | 1305 | 0.030 |
Why?
| | Visual Acuity | 1 | 2014 | 320 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1998 | 714 | 0.020 |
Why?
| | Risk Factors | 1 | 2004 | 9727 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 1936 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 1998 | 1639 | 0.020 |
Why?
| | Humans | 2 | 2017 | 128524 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3117 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3023 | 0.020 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 57 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2007 | 374 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2007 | 423 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2002 | 805 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1669 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2002 | 820 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1770 | 0.010 |
Why?
|
|
Reuter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|